Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2011-05-24
2011-05-24
Arnold, Ernst (Department: 1613)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C424S439000, C514S557000, C514S558000
Reexamination Certificate
active
07947737
ABSTRACT:
This invention relates to a method of treating hypertension and reducing serum lipase activity by dietary supplementation with conjugated linoleic acid. The method comprises administering a safe and effective amount of conjugated linoleic acid to a human. The conjugated linoleic acid may be provided in the form of a free fatty acid or chemical derivatives thereof in a pill, or as a component of a prepared food product.
REFERENCES:
patent: 3729379 (1973-04-01), Emken
patent: 4474773 (1984-10-01), Shinitzky et al.
patent: 5208356 (1993-05-01), Pariza et al.
patent: 5428072 (1995-06-01), Cook et al.
patent: 5430066 (1995-07-01), Cook et al.
patent: 5554646 (1996-09-01), Cook et al.
patent: 5585400 (1996-12-01), Cook et al.
patent: 5674901 (1997-10-01), Cook et al.
patent: 5760082 (1998-06-01), Cook et al.
patent: 5804210 (1998-09-01), Cook et al.
patent: 5814663 (1998-09-01), Cook et al.
patent: 5827885 (1998-10-01), Cook et al.
patent: 5851572 (1998-12-01), Cook et al.
patent: 5855917 (1999-01-01), Cook et al.
patent: 5856149 (1999-01-01), Pariza et al.
patent: 7157496 (2007-01-01), Kamegai et al.
patent: 440352 (1991-08-01), None
patent: 779033 (1997-06-01), None
patent: 839897 (1998-05-01), None
patent: 63036744 (1988-02-01), None
patent: WO 97/18320 (1997-05-01), None
patent: WO 97/46230 (1997-12-01), None
patent: WO 98/05318 (1998-02-01), None
patent: WO 98/49129 (1998-11-01), None
Kawamura et al. Hypertension 1996, 27, 408-413 (pp. 1 to 12 printed).
Derwent-Acc-No. 1988-087068 abstacting JP 63036744A 2 pages.
Alonso et al. (J. Dairy Sci. 2003, 86, 1941-1946).
Langer, Clin. and Exper. Hypertension, 17(7):1127-44 (1995).
Hennekens, Am. J. Medicine, 104(6A):50S-53S (1998).
Black, JAMA, 270(6):757-59 (1993).
Tietz et al., Clin. Chem. 39(5):746-56 (1993).
Thompson, Brit. Med. Bull. 46(4):986-1004 (1994).
U.S. Appl. No. 09/160,416.
U.S. Appl. No. 09/270,941.
Tonstad et al., Eur. J. Clin. Pharmacol. 46:405-10 (1994).
Chin et al., J. Food Comp. Anal. 5: 185-197 (1992).
Belury, Nut. Rev. 53(4): 83-9 (1995).
Cowan, JAOCS 72:492-99 (1950).
Marcel and Mustafa, Lipids, 32 (10) 1019-34 (1997).
Scholfield and Koritalia, “A Simple Method for Preparation of Methyl trans-10,cis-12 Octadecadienoate,” JOACS 47(8):303 (1970).
Sugano et al., “Conjugated Linoleic Acid Modulates Tissue Levels of Chemical Mediators and Immunoglobulins in Rats,” Lipids, 33(5):521-27 (1998).
Matreya Catalog, 1997, pp. 33-34.
Hudtwalcker & Co. AS Technical Data Sheet, exact publication date unknown, describes CLA compositions with various levels of CLA.
Selin CLA Product Literature, Jan. 1997, describes triglycerides incorporating CLA.
Lipid Technology Newsletter, Peter J. Barnes, Ed., vol. 4, No. 5, pp. 85-86 (Oct. 1998).
Natural Lipids Ltd. AS Technical Data Sheet, Jan. 20, 1997.
Ron Udell, Information About Conjugated Linoleic Acid, published by Soft Gel Technologies Incorporated.
Remmereit Jan
Wadstein Jan
Aker Biomarine ASA
Arnold Ernst
Casimir Jones S.C.
LandOfFree
Method of treating hypertension and reducing serum lipase... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hypertension and reducing serum lipase..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hypertension and reducing serum lipase... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2660739